NPI: 1710308085 · SPRINGFIELD, OH 45503 · Pediatrics Physician · NPI assigned 01/03/2014
Authorized official MILLER, RICHARD controls 20+ related entities in our dataset. Read more
| Authorized Official | MILLER, RICHARD (PRESIDENT AND CHIEF OPERATING OFFIC) |
| Parent Organization | OHIO PEDIATRIC CARE ALLIANCE, LLC |
| NPI Enumeration Date | 01/03/2014 |
Other providers sharing the same authorized official: MILLER, RICHARD
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 38,750 | $1.04M |
| 2019 | 38,148 | $1.07M |
| 2020 | 28,179 | $810K |
| 2021 | 25,031 | $779K |
| 2022 | 20,930 | $643K |
| 2023 | 21,263 | $657K |
| 2024 | 15,920 | $502K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 38,152 | 35,476 | $1.52M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15,142 | 14,307 | $941K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 27,666 | 23,271 | $844K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 9,835 | 9,324 | $543K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 9,014 | 8,549 | $456K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7,190 | 6,855 | $385K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4,191 | 4,013 | $249K |
| 99051 | 6,857 | 6,444 | $138K | |
| 99381 | 1,215 | 1,111 | $76K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 6,272 | 5,859 | $70K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 6,377 | 6,117 | $58K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2,042 | 1,946 | $48K |
| 96127 | 4,284 | 4,019 | $25K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1,355 | 1,253 | $24K |
| 99188 | 1,515 | 1,450 | $23K | |
| D1206 | Topical application of fluoride varnish | 1,661 | 1,610 | $22K |
| 99215 | Prolong outpt/office vis | 194 | 182 | $16K |
| 92552 | 1,021 | 973 | $11K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 748 | 680 | $10K |
| 94010 | 301 | 289 | $6K | |
| 69210 | 253 | 225 | $6K | |
| 96161 | 2,123 | 1,748 | $6K | |
| 92583 | 191 | 184 | $4K | |
| 92551 | 389 | 358 | $2K | |
| 90633 | 3,169 | 2,993 | $2K | |
| 99173 | 826 | 759 | $2K | |
| 90670 | 7,210 | 6,882 | $1K | |
| 99177 | 161 | 147 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 70 | 68 | $815.45 |
| 99382 | 13 | 13 | $689.67 | |
| 90686 | 7,792 | 7,349 | $678.72 | |
| 90671 | 1,072 | 990 | $540.50 | |
| 90710 | 1,006 | 942 | $450.70 | |
| D1208 | Topical application of fluoride, excluding varnish | 30 | 29 | $441.00 |
| A4617 | Mouth piece | 510 | 481 | $431.44 |
| 90698 | 4,564 | 4,393 | $427.71 | |
| 90620 | 166 | 157 | $359.52 | |
| 90697 | 1,434 | 1,324 | $199.41 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 13 | 12 | $175.83 |
| 90680 | 4,768 | 4,548 | $171.85 | |
| 96160 | 139 | 115 | $158.30 | |
| 90744 | 2,692 | 2,567 | $153.61 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 425 | 407 | $124.45 |
| 90651 | 1,415 | 1,320 | $113.22 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 30 | 29 | $54.75 |
| 90619 | 315 | 288 | $50.53 | |
| 90685 | 633 | 580 | $35.75 | |
| 90734 | 734 | 673 | $14.24 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 17 | 16 | $7.54 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 14 | 14 | $3.22 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 56 | 54 | $2.07 |
| J7614 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg | 14 | 14 | $0.84 |
| 91300 | 16 | 15 | $0.00 | |
| 90707 | 174 | 166 | $0.00 | |
| 90700 | 134 | 119 | $0.00 | |
| 90715 | 172 | 156 | $0.00 | |
| 90648 | 67 | 56 | $0.00 | |
| 90716 | 161 | 146 | $0.00 | |
| 91307 | 35 | 35 | $0.00 | |
| 90696 | 186 | 168 | $0.00 |